Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2019 Mar 5;33(7):1316–1324. doi: 10.1111/jdv.15539

Table 3-.

Univariate and multivariable analysis of factors associated with pruritus at entry in the study

Univariate analysis* Multivariable analysis**
VAS Pruritus
mean (SD)
P VAS pruritus variation
(95% CI)
P

Age, yrs 18–29 4.7 (3.1) 0.20 - -
30–44 4.6 (3.3) - -
45–59 4.6 (3.2) - -
60+ 4.5 (3.2) - -

Gender Male 4.4 (3.2) <0.001 Ref
Female 5.0 (3.3) 0.74 (0.59, 0.89) <0.001

BMI, kg/m2 <20.0 4.9 (3.3) 0.03 - -
20.0 – 24.9 4.5 (3.2) (0.21) - -
25.0 – 29.9 4.6 (3.2) - -
30.0+ 4.7 (3.3) - -

Smoking habits Never/Ex 4.5 (3.2) <0.001 - -
Current 4.7 (3.3) - -

Drinker No/Occasionally/Ex 4.6 (3.2) 0.96 - -
Regular 4.6 (3.2) - -

Education, yrs 0–5 (primary) 4.9 (3.3) <0.001 0.40 (0.14, 0.67) 0.003
6–8 (lower secondary) 4.7 (3.2) (<0.001) 0.41 (0.18, 0.65) 0.001
9–13 (upper secondary) 4.4 (3.2) 0.18 (−0.06, 0.41) 0.14
≥14 (university or higher) 4.3 (3.2) Ref

Marital status Unmarried 4.5 (3.2) 0.04 - -
Married / Common-law husband/wife 4.6 (3.2) - -
Divorced 4.8 (3.4) - -
Widowed 5.0 (3.4) - -

PASI score <10 3.5 (3.2) <0.001 Ref
10–20 4.6 (3.1) (<0.001) 1.01 (0.83, 1.20) <0.001
>20 5.3 (3.1) 1.63 (1.42, 1.84) <0.001

Disease duration, yrs 0–4 4.7 (3.3) <0.001 0.42 (0.17, 0.66) 0.001
5–14 4.7 (3.2) (<0.001) 0.40 (0.18, 0.61) <0.001
15–29 4.5 (3.2) 0.09 (−0.12, 0.31) 0.39
≥30 4.4 (3.2) Ref

CCI 0 4.5 (3.2) 0.001 - -
1–2 4.7 (3.3) (<0.001) - -
>2 5.0 (3.3) - -

Pustular Ps No 4.6 (3.2) 0.06 Ref
Yes 4.9 (3.3) 0.46 (0.0, 0.81) 0.049

PsA No 4.7 (3.2) <0.001 - -
Yes 4.3 (3.3) - -

Affected body areas

 Head No 4.1 (3.3) <0.001 Ref
Yes 4.8 (3.2) 0.48 (0.31, 0.65) <0.001

 Face No 4.4 (3.2) <0.001 Ref
Yes 5.0 (3.3) 0.27 (0.10, 0.44) 0.002

 Trunk No 4.1 (3.3) <0.001 - -
Yes 4.7 (3.2) - -

 Limbs No 4.2 (3.3) <0.001 - -
Yes 4.6 (3.2) - -

 Nails No 4.5 (3.2) 0.005 - -
Yes 4.7 (3.3) - -

 Palms/Feet No 4.5 (3.2) <0.001 Ref
Yes 5.0 (3.3) 0.37 (0.20, 0.54) <0.001

 Folds No 4.4 (3.2) <0.001 Ref
Yes 5.3 (3.2) 0.34 (0.16, 0.52) <0.001

 Genitalia No 4.4 (3.2) <0.001 Ref
Yes 5.4 (3.3) 0.51 (0.31, 0.71) <0.001

Previous systemic treatments for Ps 0 4.7 (3.2) 0.08 0.44 (0.21, 0.66) <0.001
1 4.6 (3.2) (0.01) 0.27 (0.04, 0.51) 0.02
2 4.5 (3.3) 0.13 (−0.11, 0.36) 0.29
3+ 4.5 (3.3) Ref

Hospital admission for Ps in the last 5 yrs No 4.5 (3.2) 0.002 - -
Yes 4.7 (3.3) - -

Previous clinical remission for Ps No 4.6 (3.2) 0.37 - -
Yes 4.5 (3.2) - -

BMI: body mass index, CCI: Charlson comorbidity index, CI: confidence interval, PASI: psoriasis area severity index, PsA: psoriasis arthritis, Ref: reference category, SD: standard deviation, VAS: visual analogue scale

*

Mann-Whitney U test for dichotomous variables or Kruskal-Wallis test for variables with three or more categories. In case of ordinal data, when the first test was significant (P-value <0.05), Cuzick’s test for trend was also performed

**

Independent factors selected in multiple linear regression analysis with forward stepwise selection algorithm

Non significant after multivariable analysis.